4DMedical Limited (ASX:4DX)
Australia flag Australia · Delayed Price · Currency is AUD
1.900
+0.060 (3.26%)
At close: Dec 5, 2025

4DMedical Company Description

4DMedical Limited operates as a medical technology company in the United States and Australia.

The company engages in the medical research technology and development of a non‑invasive respiratory imaging solution using four‑dimensional imaging.

It offers CT:VQ, non contrast post processing technology; CAC, a non-contrast cardiothoracic risk assessment sotware; CT LVAS, a regional lung function imaging software; IQ-UIP, a state-of-the-art software; LDAf, Patented Parametric Response Mapping (PRM) technology; LDAi, an automated detection of potential emphysema software; LTA provides visualization and quantification of the lung textures; PHA Analysis, a cutting-edge, fully-automated imaging solution; XV LVAS, a lung airflow imaging software; and XV Scanner, a lung function scanner.

The company was incorporated in 2012 and is based in Carlton, Australia.

4DMedical Limited
4DMedical logo
Country Australia
Founded 2012
Industry Medical Devices
Sector Healthcare
Employees 124
CEO Andreas Fouras

Contact Details

Address:
Melbourne Connect
Carlton, 3053
Australia
Phone 61 3 9545 5940
Website 4dmedical.com

Stock Details

Ticker Symbol 4DX
Exchange Australian Securities Exchange
Fiscal Year July - June
Reporting Currency AUD
ISIN Number AU0000095416
SIC Code 7372

Key Executives

Name Position
Dr. Andreas Fouras M.A.I.C.D., Ph.D. Founder, MD, Chief Executive Officer and Director
Matt Tucker Chief Commercial Officer
Chris Cox Interim Chief Financial Officer and Financial Controller
Beth Plunkett Senior Legal Counsel
Dr. Aidan Jamison B.E., Ph.D. Senior Vice President of Engineering
Rachael Tenkaten Senior Vice President of Product
Dr. Greg T. Mogel M.D. Chief Medical Officer
David Hannes B.S., M.B.A. Senior Vice President of Global Business Development
Hamish George B.Com., C.A. Company Secretary